EDGAR Filing Documents for 0001493152-20-000761

Form 8-K - Current report:

SEC Accession No. 0001493152-20-000761

Filing Date

2020-01-17

Accepted

2020-01-17 17:15:12

Documents

Period of Report

2020-01-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8k.htm	8-K	46822
2		ex4-1.htm	EX-4.1	99373
3		ex4-2.htm	EX-4.2	62891
4		ex10-1.htm	EX-10.1	80421
5		ex10-2.htm	EX-10.2	75343
	Complete submission text file	0001493152-20-000761.txt		366252

Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124

Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723

Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)